on Evotec AG (NASDAQ:EVTCY)
Evotec SE to Release Nine-Month 2024 Financial Results
Evotec SE, a life science company listed on the Frankfurt Stock Exchange and NASDAQ, plans to announce its financial results for the first nine months of 2024 on November 6. The announcement will be accompanied by a conference call, during which the management intends to discuss these results and provide insights into the ongoing priority reset and strategic review process.
The conference call, conducted in English, is scheduled for 2:00 pm CET. Participants can join via a webcast with presentation slides available for both online and phone attendees. An on-demand version of the webcast will be accessible on the company's website.
Evotec, known for its multimodality platform, engages in partnerships to advance therapeutics across various fields including neurology, oncology, and infectious diseases. The company's global operations employ over 5,000 individuals with strategic activities focused in Europe and the USA.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news